IO Biotech pockets Series B
IO Biotech, a Danish clinical-stage biopharmaceutical company, has raised 127 million euros in Series B financing.
IO Biotech, a Danish clinical-stage biopharmaceutical company, has raised 127 million euros in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination
